Kevin F. Hanley, See Remarks at OCULAR THERAPEUTIX, INC (OCUL), bought 10,000 shares at $5.50 ($55K) on 2018-12-14, disclosed to the SEC on 2018-12-18.
Open-market purchase of $55k OCUL by See Remarks. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.